ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002